drugset / Trial / NCT06539494

Luminal Fructose Kinetics (MARTINI Study)

NCT06539494

Phase 2 Recruiting 22 enrolled Academic Medical Center - University of Amsterdam
Non-randomizedParallel-groupOpen-labelBasic science

Summary

In this study the investigators aim is to explore the dynamics of (small) intestinal fructose catabolism in humans and ethanol production in relation to small intestinal signalling pathways and changes in pH, using 13C fructose isotope tracing techniques complemented with direct luminal sampling via small intestinal catheter in biopsy proven MASLD/MASH patients vs healthy (BMI\<25) subjects. Additionally the investigators will repeat the experiment after four weeks of administering omeprazole at a dose of 40 mg twice daily. Omeprazole is a proton pump inhibitor, known to elevate pH from 2-6.

Timeline

Start
2024-07-01
Primary completion
2026-01
Completion
2026-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omeprazole Other / unclassified 40 mg Oral